Health Archive » April, 2011

Health - April, 2011

270 articles

• Actelion Must Pay Asahi $550M In Fasudil Suit: Jury
• Ex-MedQuist CFO Settles SEC Suit Over Billing Fraud
• Ex-Hospital Exec Gets Bench Trial In Bribery Case
• Billups' Gene Test Patents Are Invalid: Fed. Circ.
• Big Tobacco Wins $455M Fight Against Mo. Hospitals
• New Medicare Program Rewards Hospitals For Performance
• How The FDA Can Compel Post-Marketing Studies
• Lilly, SEC Push Toward Deal In FCPA Probe
• DC Circ. OKs Funding For Embryonic Stem Cell Research
• Mass. Hospital Wins Gene Patent Inventorship Fight
• Expertly Navigating Federal Expert Disclosure Rules
• Celgene Sues Americord Over Stem Cell Marketing
• Shire Sues Sandoz Over Planned Generic Intuniv
• Allergan Hit With $212M Verdict In Botox Suit
• Researcher Renews CVS Fight Over Prescription Data
• EU Probes Cephalon, Teva Deal Over Generic Provigil
• CHS Rebuts Tenet Medicare Fraud Claims
• FDA Must Act Quickly On Ranbaxy Lipitor ANDA: Mylan
• Merck To Abide By Discharge Diet To End Enviro Suit
• NAIC Wins Suit Over Medicare Supplement Criticisms
• Davis Polk Reps Aetna In $600M Prodigy Health Buy
• Using Injunctions In 'Bet-The-Company' Litigation
• Weighing Generic Litigation In The ITC
• Par Pharmaceutical Settles Medicaid Suits For $154M
• Lilly Wins Order Banning Generic Cymbalta Sales
• Abbott Appeals $3.5M OT Ruling In 7th Circ.
• Genzyme Sues Over Endo's Bid To Sell Generic Renvela
• Asahi, Actelion Throw Final Punches In Fasudil IP Row
• Mayo Wins Trade Secrets Verdict Against Ex-Employee
• Prexus Wins $8M Verdict In Texas Contract Suit
• Duane Reade Settles Medicaid Fraud Suit
• Albemarle Hit With CWA Suit Over Pharma Production
• FOIA Request Filed As Avastin Safety Hearing Nears
• Hospira, Others Sued Over Infusion Pump Patent
• FTC Orders Hikma To Shed Drugs For $112M Baxter Deal
• Cravath, Weil Rep J&J In $21B Deal To Buy Synthes
• Mo. Lt. Gov. Loses Health Care Reform Suit
• Hospital Group To Appeal PPACA Suit Dismissal
• High Court Mulls Vt. Limits On Use Of Drug Data
• Former NC Chief Justice, 3 Others Join Nexsen Pruet
• UnitedHealth, Workers Should Arbitrate OT Row: Judge
• Elan Targets Teva Again Over Generic Focalin XR
• $251M Animal Health Co. Merger Moves Forward
• Metro Med Workers Sentenced For $23M Medicare Fraud
• Genzyme Asks To Add New Patent To Arthritis Drug Suit
• Pharmacist Hits Omnicare With Meal Break Class Action
• Judge Allows Revival Of Claims In Radiology FCA Suit
• FDA To Repackage E-Cigarettes As Tobacco Products
• Baxter, CSL Look To Nix County's Blood Plasma Suit
• WHPM Hit With $20M Suit Over Drug Test Kits
• No Proof For Bayer's Probiotics Claims, Suit Says
• Supreme Court Rejects Fast-Track Health Care Appeal
• Mutual Sues West-Ward Over Gout Drug Patents
• Community Health Under Microscope For Medicare Billing
• AstraZeneca, Pozen Sue Dr. Reddy's Over Vimovo Patent
• St. Jude Wins $2.3B Verdict In Trade Secrets Trial
• Employers With No-Smokers Policies Could Get Burned
• Northgate Infringes Lexion Laparoscopy IP: Fed. Circ.
• Fast-Track Patent Review Delayed By Budget Woes
• Yaz, Similar Pills Tied To Higher Blood Clot Risks
• Tenet Healthcare Again Rejects $3.3B CHS Bid
• FTC Won't Bar LabCorp's $58M Westcliff Tie-Up
• Plaintiffs Fear Retaliation In MiraLax Antitrust Suit
• Genentech Sues Sandoz Over Generic Valcyte
• The Dawn Of Internet Privacy?
• Judge Nixes New Trial For Braun, Terumo Catheter Row
• Ranbaxy Can't Dodge Lupin's Suit Over Generic Antara
• ERISA Preempts Hospital's Contract Claims: 2nd Circ.
• Fund Wants J&J To Pay Up For Faulty Hip Implants
• Class Cert. Denied In Pitt ADA Suit
• Cardinal Health Settles Kickback Claims For $8M
• Calif. Calls On Blue Shield To Explain 38% Rate Hike
• FDA Cautions Lifetech Over Eyelash Growth Products
• Feds Seek Deal Time In $3M FDA Chemist Trading Case
• Sanofi Free To Appeal Genentech Patent Ruling
• GSK, Scottrade Settle IP Suits Over Navy Technology
• Medicaid Claims Processor Dodges FCA Suit
• Shire Sues Mylan Over Intuniv Patents
• Wyeth, Dr. Reddy's Strike Deal Over Effexor Patents
• Certifying To Medical Necessity Under FDA
• Contractor Wants Hospital Kickback Case Pruned
• Feds Want GSK VP To Testify In Wellbutrin Case
• Aetna Loses Bid To Re-Enter Pfizer Off-Label MDL
• Bayer Sues Mylan Over Generic Yaz
• Novartis Targets Teva Over Myfortic Patents
• FTC Seeks To Block Ga. Hospital Merger
• The Scope Of Protective Orders For Medical Records
• No New Trial For Former InterMune CEO
• US Cracks Down On Prescription Drug Abuse
• Judge Tosses Most Claims In Medtronic Class Action
• Marketing Reps Hit Amerigroup With OT Class Action
• Off-Label Use Of Novo Drug May Harm Patients: Study
• AstraZeneca Sued Over Nexium Bone Fracture Risks
• Texas Hospital Fights To Sink Medicare Fraud Suit
• 2nd Circ. Nixes Suit Over University's Medicare Bills
• FTC Clears Warburg's $438M Rural/Metro Buyout
• Genzyme, Daiichi Sue Watson Over Generic Welchol
• Mich. Hospitals Try To Nix Price-Fixing Action
• Baker & Daniels Adds 2 Partners In Chicago
• Defense Absent As St. Jude Trade Secrets Trial Begins
• Caraco Investors Seek Class Cert. In Stock Price Suit
• Suits Force Celera's Hand On $344M Merger With Quest
• Skilling Ruling Dooms Hospital Bribery Case: Contractor
• Allergan Targets Sandoz Over Generic Latisse
• McCarter Adds Patent Attorney From Foley & Lardner
• Synthes Confirms Potential $20B Acquisition By J&J
• AstraZeneca, P&G Dodge Prilosec OTC Antitrust Suit
• CHS Moves To All-Cash Bid In Tenet Merger Battle
• 'Love And Other Drugs' In Real Life
• Harmonizing FDA Foreign And Domestic Inspections
• Welcome To The New Law360
• Merck, J&J Strike Deal In Arthritis Drugs Dispute
• FDA Ducks ViroPharma Suit Over Generics Guidelines
• Biotech Co., Mintz Levin Settle Suit Over Patents
• CVS Pays $17.5M To End False Claims Act Suit
• UK To Ban Lethal Injection Drug Exports To US
• Cypress Sued Over Unapproved Cold Medication
• FDA Issues Safety Warning On Teva's Generic Prevacid
• FTC Must Break Up CVS Caremark: Consumer Groups
• Ala. High Court Again Rejects Scrushy Appeal
• Gentiva Clinicians Win Conditional Cert. In Pay Suit
• Calif. Court Lets P&G Fight Align Suit On Home Turf
• Judge Blocks Par Pharma's Generic Treximet
• Wyeth, Orchid Reach Deal In Effexor Patent Fight
• Making Good Lawyers Into Great Partners
• UK Court Strikes Down Infosint Patent In Citalopram Suit
• Health Care Co. Owners Cop To $200M Medicare Fraud
• UHS Demands More Info From Rival In Antitrust Suit
• NH Can Deduct Premium From Pensions, Court Rules
• House Committee Advances Amended Patent Bill
• Ex-InterMune CEO Gets House Arrest For Drug Claims
• UBS Urges 2nd Circ. To Nix Hospital Co.'s ARS Win
• Ex-GSK Lawyer Faces New Obstruction Indictment
• Genzyme Sues Seikagaku Over Synvisc-One Patent
• FDA Recalls Radiation Shield That Sheds Tungsten
• Axcan To Pay Up To $230M For Rival Mpex
• Penumbra Pulls Aneurysm Device Over Deadly Defects
• JPML To Weigh Consolidation Of Darvocet Cases
• Arguments On Appeal: FTC V. Lundbeck
• Takeda Drops Suit Over Apotex's Actos ANDA
• J&J Recalls 57K Bottles Of Topamax Over Odor
• House Votes To Strip $18B Health Care Law Fund
• Coventry Seeks KO In Securities Class Action
• HGS Fires Round 2 At Genentech Over Lupus Drug IP
• Bill Seeks To Temper FDA Oversight Of Drug Imports
• FDA Warns Philips Over Fatal Defibrillator Defects
• Zyprexa Payors Ask High Court For Shot At Eli Lilly
• FDA Must Improve Medical Device Oversight, GAO Says
• Vioxx MDL Attys Want 3 Firms Backing Fee Plan KO'd
• FDA Urged To Help Get Prandin Row To High Court
• Smiths Medical Sued Over Suction System Patent
• Calif. Wades Into Sutter Health Insurance Fraud Suit
• Lawyers Trade Blows Over Asahi, Actelion Trial Conduct
• MetroPlus, HHC Evade State Claims In OT Action
• Baker Donelson Lures Ala. Health Care Vet
• Braun Can't Dodge False Marking Claims On IV Fluids
• Judge Says Cordis Stent Infringes BSC Patent
• Medical Supplier Gets 6 Months For Hussein Kickbacks
• Quest's $344M Celera Buy Averts Antitrust Hurdle
• Feds Charge FrontPoint Trader In $30M Inside Tips Case
• Allied Health Founder Cops To $87M Lease Fraud
• Moog Infusion Pumps Face Class I Recall
• Medical Group Kept Egg Prices Low, Donor Claims
• Judge Trims State Claims From Res-Care FLSA Suit
• Hospitals Urge Court To Revive UnitedHealth Fraud Suit
• Fed. Circ. Rejects McKesson's Bid To Revive IP Suit
• Inspire Investor Challenges $430M Merck Deal
• Parties Offer Bellwether Plan In NuvaRing MDL
• Democrat AGs Defend Health Care Law In 11th Circ.
• NY Legislators, 6 Others Deny Bribery Charges
• Ropes & Gray Nabs IP Litigator From Sidley
• Practice Advice For Privacy Breaches
• Fresenius Dialysis Device Faces FDA Scrutiny
• Chem Rx Liquidation Plan Wins OK After Amendments
• Hologic Sues IZI Over Mammogram Cushion Patent
• Sidley Reps SXC In UMass Benefits Manager Pickup
• Dr. Comfort, Founder To Pay $27M For Medicare Fraud
• Purdue Sues Impax, Ranbaxy Over Generic OxyContin
• Revlimid Cancer Woes Spark FDA Safety Review
• Mo. AG Backs Health Care Law Challenge In 11th Circ.
• Tenet Lobs Fraud Suit At Hostile Suitor CHS
• FTC Blesses Kindred's $1.3B RehabCare Purchase
• The Latest On Advance Directives
• Former US Rep. Stupak Joins Venable Policy Group
• Merck, Sun Pharma Form Generics Joint Venture
• Skadden Reps Endo In $2.9B American Medical Buy
• Quest Settles Suit Over Unpaid Cell Phone Expenses
• Subcontractors Denied Cert. In $13M UnitedHealth Suit
• Judge Says No To Generic Amrix
• Nautilus Sues Wockhardt Over Cambia ANDA
• Abbott To Pay $52M To Norvir Direct Purchaser Class
• Pfizer Wins Approval Of Unit's $265M Asbestos Deal
• DOJ Backs $245M Stericycle Deal With Plant Sale
• UK Court Shutters Merck's Cosopt Patent Fight
• St. Vincent's Inks $260M Sale To Real Estate Kingpin
• GSK Rival Barred From Infringing Aquafresh Mark
• No Sympathy For Off-Label Scripts Suits
• Fla. Marketing Director Cops To $100M Medicare Fraud
• Investor Sounds Siren On $438M Offer For Rural/Metro
• J&J Pays $78M To Settle Foreign Bribery Cases
• NY Lawmakers, Hospital CEOs Get More Bribery Charges
• Judge Nixes Releases In Chem Rx Ch. 11 Plan
• FDA Blasts Mylan Suit Over Generic Lipitor Exclusivity
• AmSurg Nabs Rival Surgery Center Operator For $174M
• Minsurg Infringement Claims Survive Dismissal Bid
• Alcon Sues Watson Over Vigamox Patents
• Shareholder Suits Over Genoptix Sale Consolidated
• Blinded Mexican Patients Can Bring US Suit: 9th Circ.
• Angiotech Wins US Approval Of Canada Restructuring
• UnitedHealth Wins Protest Of Military Care Contract
• Kaye Scholer Reps Novartis In $420M Elidel Sale
• Canopy Ex-CEO Must Pay Back $2M For $93M Fraud
• Deformed Consent
• Judge Tosses Challenge To FDA Supplement Rules
• FDA Orders Seizure Of $6M In Products At Triad Plant
• House Panel Advances Bills To Defund Health Care Law
• Ex-Unilab GC Participation Dooms Relator's FCA Case
• Fla. Hospital Not Immune To FCA Suit, US Says
• Jury To Weigh Lost Profits In Neurontin Patent Fight
• Shire Sues Watson Again Over Adderall Patents
• Ex-NY Sen. Espada, Son Deny Corruption Charges
• Is It Material? Depends On Who You Ask
• Cravath Reps Genpact In $550M Headstrong Buy
• The FTC And State Health Care Regulation
• Cephalon Board Rejects Valeant's $5.7B Merger Bid
• Health Net Could Pay $180M Over Failed HMOs
• EMS Investors Add Goldman Sachs To Suit Over Buyout
• Pfizer Securities Fraud Suit Must Stay In NJ: Judge
• Ortho Can't Shake False Marking Claims On 5 Drugs
• Galderma, Dermalogix End Clobex Suit Against Paddock
• Eckert Seamans Snags Ex-Mass. Rep. Delahunt
• 166 Plaintiffs Tossed From Neurontin MDL
• Claims Trimmed In Radiology Co. Qui Tam Suit
• Fed. Circ. Mulls Smith & Nephew $5.2M Patent Win
• FTC Clears Cephalon's $225M Gemin X Buyout
• Palmetto Targets AstraZeneca's Crestor In IP Suit
• Hill-Rom Targets Stryker Over Bed, Stretcher Patents
• Ex-AmeriPath Manager Breached Noncompete: Judge
• Waiting For An Adult Conversation On Health Care
• Fried Frank Reps Merck In $430M Inspire Deal
• 7 Ways To Avoid Privacy And Data Security Trouble
• Lilly Sues Generics Maker Over Zyprexa Patent
• Lupin Unit Sues Ranbaxy Again Over Generic Antara
• HHS Wants To Loosen Medicare Supplier Rules
• Conceptus Fired Salesman For Overbilling Report: Suit
• Congress Can Mandate Health Insurance, US Says
• Amgen Expert Report Allowed In Aranesp Kickback Suit
• Myriad Pushes For Isolated DNA Patents In Fed. Circ.
• Cubist, Teva Settle IP Suit Over Generic Cubicin
• NC Hospital To Pay $1.9M To End Medicare Fraud Suit
• Abbott, Elan Drop Tricor IP Suits Against Biovail
• WellPoint, Ex-Workers Settle Age Bias Suits For $2.6M
• Takeda Targets Dr. Reddy's Over Generic Dexilant
• A Winning Strategy For Beating IPO Class Actions
• Taming Of The 'Ostrich Officers'
• Ohio Willow Dodges Sanctions In Prosthetics IP War
• Simpson Reps KKR In $2.4B Pfizer Capsule Unit Buy
• ReGen Using Menaflex IP After Rights Transfer: Suit
• BSC Poached Worker Suit To Move Forward In Calif.
• Eurand, Anesta Sue Anchen Over Generic Amrix
• DOJ Sues Healthpoint Over Zenaderm Marketing
• Stryker Claims Zimmer Stole Employees
• Mintz Levin Lures Ober Kaler Health Antitrust Guru
• Dead Ala. Woman's Estate Sues Over Tainted IV
• US, EU Antitrust Heads Vow Cooperation, Enforcement
• Allergan Sues Lupin Over Zymaxid Patents
• Drug Test Co. Lured Doctors With Kickbacks, Rival Says
• HIF, BizBiotech Must Face IP Claims In Federal Court
• Navigating The Medicare Secondary Payer Minefield
• Judge Denies Injunction In Animal Imaging IP Spat